[Guiding- acupuncture for dry eye syndrome].

Zhongguo Zhen Jiu

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM, Shanghai 200437, China.

Published: February 2018

Objective: To observe the clinical efficacy differences between different needling methods for dry eye syndrome.

Methods: Sixty patients of dry eye syndrome were randomly divided into an observation group and a control group, 30 cases (60 eyes) in each group. Shangjingming (Extra), Xiajingming (Extra), Tongziliao (GB 1), Cuanzhu (BL 2), Fengchi (GB 20), Hegu (LI 4), Sanyinjiao (SP 6), Taixi (KI 3) and Taichong (LR 3) were selected in the two groups. The control group was treated with conventional acupuncture, while the observation group was treated with guiding- acupuncture. Electroacupuncture (EA) was used at bilateral Tongziliao (GB1) and Cuanzhu (BL 2), 30 min per treatment. The treatment was given three times per week. Totally 1-month treatment (12 treatments) was given. The eye symptom score, breakup time of tear film (BUT), Schirmer Ⅰ test (SⅠT) and visual analogue scale (VAS) score were compared before and after treatment in the two groups. The clinical efficacy was compared between the two groups.

Results: Compared before treatment, the eye symptom score, BUT, SⅠT and VAS score were improved after treatment in the two groups (all <0.001); the improvements of eye symptom score and SⅠT in the observation group were superior to those in the control group (both <0.05). The differences of BUT and VSA score between the two groups were not significant (both >0.05). The total effective rate was 86.7% (52/60) in the observation group, which was superior to 73.3% (44/60) in the control group (<0.05). .

Conclusion: The conventional EA and guiding- acupuncture combined with EA are both effective for dry eye syndrome, and the efficacy of guiding- acupuncture combined with EA is superior to that of conventional EA.

Download full-text PDF

Source
http://dx.doi.org/10.13703/j.0255-2930.2018.02.012DOI Listing

Publication Analysis

Top Keywords

dry eye
12
clinical efficacy
8
observation group
8
control group
8
group treated
8
eye symptom
8
symptom score
8
vas score
8
compared treatment
8
treatment groups
8

Similar Publications

Ocular Surface Disease Index questionnaire in different languages.

Med Hypothesis Discov Innov Ophthalmol

February 2025

School of Graduate Studies (SGS), Management & Science University (MSU), Shah Alam, Selangor, Malaysia.

Background: The Ocular Surface Disease Index (OSDI) questionnaire was first introduced and developed in 1997 by the Outcomes Research Group, and was adopted by Allergan, Inc. (Irvine, Goleta, CA). While several tools are available for evaluating dry eye syndrome (DES), the OSDI questionnaire is known to have high reliability and validity.

View Article and Find Full Text PDF

Background: Faricimab is a novel anti-vascular endothelial growth factor agent, used to treat patients with neovascular age-related macular degeneration (nAMD). This study assessed efficacy and safety of faricimab in previously treated eyes.

Methods: This retrospective study included previously treated nAMD patients who had received at least three faricimab injections.

View Article and Find Full Text PDF

Eye washing is a common over-the-counter, self-administered method for managing hay fever-related ocular symptoms. However, epidemiological data on eyewash users with hay fever and their characteristics are limited. This study aimed to profile eyewash usage and preferences in individuals with hay fever.

View Article and Find Full Text PDF

SIRT3 mitigates dry eye disease through the activation of autophagy by deacetylation of FOXO1.

Exp Eye Res

March 2025

Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Nanjing, China. Electronic address:

Dry eye disease (DED) is a complex ocular condition characterized by oxidative stress, inflammation, and apoptosis. An increasing number of studies suggest that Sirtuin3 (SIRT3), a mitochondrial deacetylase, may offer protection against related pathologies. Despite these indications, the precise function and underlying mechanisms of SIRT3 in the context of DED have not been fully elucidated.

View Article and Find Full Text PDF

Thyroid associated eye disease combined with dry eyes is a common clinical disease and has gradually received clinical attention. Its onset is caused by various factors such as eyelid dynamic change and immune inflammation, involving tear secretion, tear discharge, tear quality and other aspects. This article systematically reviews the research related to its immune factors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!